The Life Science C-Suite's Top 3 Outsource Considerations

Sponsored By DDN

Topics:

Budgeting & Planning

Compliance & Governance

Finance & Risk Management

View White Paper now

Free registration is required

Abstract:

The title of this white paper is the Life Science C-Suite's Top 3 Outsource Considerations. We wrote this white paper to assist CFOs (and other members of the C-suite) with outsource decisions by providing summaries of three key areas of consideration when contemplating outsourcing - business, financial and partnership considerations. The white paper asserts that of the many fiduciary responsibilities held by the C-suite -- increasing economic value, or return on invested capital - can be positively impacted by reducing costs, both operating and capital, through outsourcing. We've cited statistics and recent reports throughout the paper, provided a list of outsource evaluation filters, detailed related regulations/standards and concluded with an outsource provider comparative checklist.

DETAILS

Sponsored by: DDN

Released: October 29, 2009

Length: 7 pages

Format: PDF (490 kb)

Email this abstract

These white papers are not created by the CFO.com editorial staff. In order to view these papers, you must register with CFO.com and agree to share your contact information with related product/service companies.

Search White Papers